Haemonetics Corporation (HAE) Financials
HAE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 2.4 billion | 1.5 billion |
| March 31, 2026 | 2.4 billion | 1.6 billion |
| Dec. 31, 2025 | 2.5 billion | 1.6 billion |
| Sept. 30, 2025 | 2.4 billion | 1.6 billion |
HAE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 44.4 million | 9.3 million |
| March 31, 2026 | 53.3 million | 9.1 million |
| Dec. 31, 2025 | 87.2 million | 7.8 million |
| Sept. 30, 2025 | 106.3 million | 7.6 million |
HAE Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 33.0 million |
| March 31, 2026 | -20.1 million |
| Dec. 31, 2025 | 44.7 million |
| Sept. 30, 2025 | 38.7 million |
HAE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 223.4 million | 1.2 billion | - |
| March 31, 2026 | 245.4 million | 1.2 billion | - |
| Dec. 31, 2025 | 363.4 million | 920.0 million | - |
| Sept. 30, 2025 | 296.4 million | 920.4 million | - |
HAE Shares Outstanding
HAE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 7.9 million | 16.2 million | 118.9 million | - |
| March 31, 2026 | 17.7 million | 14.4 million | 121.8 million | - |
| Dec. 31, 2025 | 6.3 million | 14.3 million | 107.6 million | - |
| Sept. 30, 2025 | 5.0 million | 14.5 million | 101.6 million | - |
HAE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 339.4 million | 136.6 million |
| March 31, 2026 | 346.4 million | 148.1 million |
| Dec. 31, 2025 | 339.0 million | 147.6 million |
| Sept. 30, 2025 | 327.3 million | 143.9 million |
HAE Revenue by Segment
Graph available only for paid members. Upgrade to see it.
HAE
Price: $120.88
52 week price:
Earnings Per Share: 2.16 USD
P/E Ratio: 42.29
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 121503
Ebitda: 23.3 millionMarket Capitalization: 4.7 billion